ProText Mobility Inc (TXTM)

[Organic2]

IMPORTANT QUICK SOUTH AFRICA MEDICAL MARIJUANA LAW DD

This was a few months ago. You will see they require strict security standards... IE blockchain... AKA phytocoin. This is going to be yuge. They even reference "plant material" Could that be because plant material is what TXTM is producing?!?! The wording is there. It's so close You can smell it...

https://www.iol.co.za/sundayindependent/analysis/medical-marijuana-bill-rejected-but-12157890

"Mario Oriani-Ambrosini introduced the Medical Innovation Bill in Parliament in September 2014. The MP was then diagnosed with terminal lung cancer and commenced a campaign to legalise the medical use of cannabis.
The objectives of the bill are to legalise and regulate the use of cannabinoids for medicinal purposes, commercial and industrial use of cannabis.

Parliament’s Portfolio Committee on Health rejected the bill on Wednesday.

The bill was rejected as the Medicines and Related Substances Act already provides a legal framework for the use of cannabis for medicinal and research purposes.

The introduction of the private member's bill shed light on the plight of many cancer sufferers and terminally ill patients seeking alternative medication.


A statement from an MP during the committee deliberations on the bill emphasised the objective of the parliamentary process is to preserve life and ensure that terminally ill patients do not have to struggle to obtain pain-relieving medication.

The committee received several briefings from the public, including the Medicines Control Council (MCC) of the Department of Health; the Central Drug Authority, clinician experts and medical researchers.

As the Medicine Act already made provision for use of cannabis for medical purposes, the committee looked at what could be done to make cannabis for medical use more accessible to terminally ill patients.

Cannabis is listed as a Schedule 7 substance in the schedules to the act, which makes possession of the plant illegal. However, all products imported and sold with claims relating to therapeutic effects are scheduled as Schedule 6 medicines.

As a Schedule 6 medicine, the act makes provision for a person wishing to sell an unregistered medicine for purposes other than a clinical trial, to make an application in terms of the act. This application can be made in terms of section 14 of the Medicines Act.

Sections 22A (9)(i) and 21 enable the use of an unregistered drug under specific conditions with permission from the director-general of the Health Department. A valid medical reason for requiring cannabis use for therapeutic effects is necessary. The application form is available on the website of the MCC.

Cannabidiol (or more commonly known as CBD or dagga oil) is rescheduled as a Schedule 4 substance. This means that you can obtain the medicine with a prescription from a medical practitioner only.

Section 22C(1)(b) of the Medicines Act makes provision for the cultivation and growing of cannabis; manufacturing; importation; exportation; and distribution of cannabis-containing medicines. The MCC has developed guidelines for growing cannabis for medicinal and research purposes.

The aim is to provide minimum operating procedures relating to the cultivation of cannabis and manufacture of cannabis-related pharmaceutical products.

Licensed domestic cultivation of medicinal cannabis will be aimed at ensuring the supply of a standardised, quality-assured product for medical, scientific and clinical research purposes, and the implementation of control measures necessary to prevent misuse and to ensure patient safety.

Cannabis grown or cultivated for medicinal purposes, as well as any resulting products prepared from the plant material, will remain subject to stringent security and quality control measures.
"